AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 78 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $476,000,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,238,322 | $4,177,000 | 1.35% |
| Noven Financial Group, Inc. | 252,667 | $326,000 | 0.22% |
| Trellus Management Company, LLC | 80,000 | $103,000 | 0.17% |
| Transform Wealth, LLC | 146,692 | $189,000 | 0.08% |
| Fort Point Capital Partners LLC | 121,400 | $157,000 | 0.08% |
| Camelot Portfolios, LLC | 36,000 | $46,000 | 0.03% |
| GHP Investment Advisors, Inc. | 90,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 328,300 | $424,000 | 0.01% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $23,000 | 0.01% |
| WealthTrust Axiom LLC | 10,000 | $12,000 | 0.01% |